-
1
-
-
34447336141
-
The complement system in liver diseases
-
Qin X, Gao B. The complement system in liver diseases. Cell Mol Immunol 2006; 3: 333-340.
-
(2006)
Cell Mol Immunol
, vol.3
, pp. 333-340
-
-
Qin, X.1
Gao, B.2
-
2
-
-
52949138251
-
The role of complement in the mechanism of action of rituximab for B-cell lymphoma: Implications for therapy
-
Zhou X, Hu W, Qin X. The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy. Oncologist 2008; 13: 954-966.
-
(2008)
Oncologist
, vol.13
, pp. 954-966
-
-
Zhou, X.1
Hu, W.2
Qin, X.3
-
3
-
-
20944444434
-
"Homologous restriction" in complement lysis: Roles of membrane complement regulators
-
Morgan BP, Berg CW, Harris CL. "Homologous restriction" in complement lysis: roles of membrane complement regulators. Xenotransplantation 2005; 12: 258-265.
-
(2005)
Xenotransplantation
, vol.12
, pp. 258-265
-
-
Morgan, B.P.1
Berg, C.W.2
Harris, C.L.3
-
4
-
-
0033064619
-
Regulation of the complement membrane attack pathway
-
Morgan BP. Regulation of the complement membrane attack pathway. Crit Rev Immunol 1999; 19: 173-198. (Pubitemid 29321438)
-
(1999)
Critical Reviews in Immunology
, vol.19
, Issue.3
, pp. 173-198
-
-
Morgan, B.P.1
-
5
-
-
0035810399
-
Complement. First of two parts
-
Walport MJ. Complement. First of two parts. N Engl J Med 2001; 344: 1058-1066.
-
(2001)
N Engl J Med
, vol.344
, pp. 1058-1066
-
-
Walport, M.J.1
-
6
-
-
0021215772
-
Complement. Historical perspectives and some current issues
-
Mayer MM. Complement. Historical perspectives and some current issues. Complement 1984; 1: 2-26.
-
(1984)
Complement
, vol.1
, pp. 2-26
-
-
Mayer, M.M.1
-
7
-
-
0010991242
-
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement
-
DOI 10.1073/pnas.84.7.2007
-
Medof ME, Lublin DM, Holers VM, Ayers DJ, Getty RR, Leykam JF et al. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci USA 1987; 84: 2007-2011. (Pubitemid 17054138)
-
(1987)
Proceedings of the National Academy of Sciences of the United States of America
, vol.84
, Issue.7
, pp. 2007-2011
-
-
Medof, M.E.1
Lublin, D.M.2
Holers, V.M.3
-
8
-
-
0022465626
-
Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein
-
DOI 10.1084/jem.163.5.1150
-
Davitz MA, Low MG, Nussenzweig V. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). J Exp Med 1986; 163: 1150-1161. (Pubitemid 16000414)
-
(1986)
Journal of Experimental Medicine
, vol.163
, Issue.5
, pp. 1150-1161
-
-
Davitz, M.A.1
Low, M.G.2
Nussenzweig, V.3
-
9
-
-
0021922659
-
Deficiency of the complement regulatory protein, "decay-accelerating factor," on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria
-
Nicholson-Weller A, Spicer DB, Austen KF. Deficiency of the complement regulatory protein, "decay-accelerating factor," on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria. N Engl J Med 1985; 312: 1091-1097.
-
(1985)
N Engl J Med
, vol.312
, pp. 1091-1097
-
-
Nicholson-Weller, A.1
Spicer, D.B.2
Austen, K.F.3
-
10
-
-
0034292339
-
Cooperation between decay-accelerating factor membrane cofactor protein in protecting cells from autologous complement attack
-
Brodbeck WG, Mold C, Atkinson JP, Medof ME. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack. J Immunol 2000; 165: 3999-4006. (Pubitemid 32057311)
-
(2000)
Journal of Immunology
, vol.165
, Issue.7
, pp. 3999-4006
-
-
Brodbeck, W.G.1
Mold, C.2
Atkinson, J.P.3
Medof, M.E.4
-
11
-
-
0024430596
-
Molecular cloning and characterization of MACIF, an inhibitor of membrane channel formation of complement
-
Sugita Y, Tobe T, Oda E, Tomita M, Yasukawa K, Yamaji N et al. Molecular cloning and characterization of MACIF, an inhibitor of membrane channel formation of complement. J Biochem (Tokyo) 1989; 106: 555-557. (Pubitemid 19241820)
-
(1989)
Journal of Biochemistry
, vol.106
, Issue.4
, pp. 555-557
-
-
Sugita, Y.1
Tobe, T.2
Tomita, M.3
Yasukawa, K.4
Yamaji, N.5
Takemoto, T.6
Furuichi, K.7
Takayama, M.8
Yano, S.9
Oda, E.10
-
12
-
-
0346656612
-
Complement and complement regulatory proteins as potential molecular targets for vascular diseases
-
DOI 10.2174/1381612043453441
-
Acosta J, Qin X, Halperin J. Complement and complement regulatory proteins as potential molecular targets for vascular diseases. Curr Pharm Des 2004; 10: 203-211. (Pubitemid 38072756)
-
(2004)
Current Pharmaceutical Design
, vol.10
, Issue.2
, pp. 203-211
-
-
Acosta, J.1
Qin, X.2
Halperin, J.3
-
13
-
-
0038664378
-
Role of complement in the control of HIV dynamics and pathogenesis
-
DOI 10.1016/S0264-410X(03)00203-2
-
Stoiber H, Speth C, Dierich MP. Role of complement in the control of HIV dynamics and pathogenesis. Vaccine 2003; 21(Suppl 2): S77-S82. (Pubitemid 36588652)
-
(2003)
Vaccine
, vol.21
, Issue.SUPPL. 2
-
-
Stoiber, H.1
Speth, C.2
Dierich, M.P.3
-
14
-
-
0035018461
-
The supportive role of complement in HIV pathogenesis
-
DOI 10.1034/j.1600-065X.2001.1800115.x
-
Stoiber H, Kacani L, Speth C, Wurzner R, Dierich MP. The supportive role of complement in HIV pathogenesis. Immunol Rev 2001; 180: 168-176. (Pubitemid 32472861)
-
(2001)
Immunological Reviews
, vol.180
, pp. 168-176
-
-
Stoiber, H.1
Kacani, L.2
Speth, C.3
Wurzner, R.4
Dierich, M.P.5
-
15
-
-
0025202520
-
Activation of the complement system in human immunodeficiency virus infection: Relevance of the classical pathway to pathogenesis and disease severity
-
Senaldi G, Peakman M, McManus T, Davies ET, Tee DE, Vergani D. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity. J Infect Dis 1990; 162: 1227-1232.
-
(1990)
J Infect Dis
, vol.162
, pp. 1227-1232
-
-
Senaldi, G.1
Peakman, M.2
McManus, T.3
Davies, E.T.4
Tee, D.E.5
Vergani, D.6
-
16
-
-
0027393761
-
Complement activation by human monoclonal antibodies to human immunodeficiency virus
-
Spear GT, Takefman DM, Sullivan BL, Landay AL, Zolla-Pazner S. Complement activation by human monoclonal antibodies to human immunodeficiency virus. J Virol 1993; 67: 53-59.
-
(1993)
J Virol
, vol.67
, pp. 53-59
-
-
Spear, G.T.1
Takefman, D.M.2
Sullivan, B.L.3
Landay, A.L.4
Zolla-Pazner, S.5
-
17
-
-
33845288582
-
Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection
-
Huber M, Fischer M, Misselwitz B, Manrique A, Kuster H, Niederost B et al. Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection. PLoS Med 2006; 3: e441.
-
(2006)
PLoS Med
, vol.3
-
-
Huber, M.1
Fischer, M.2
Misselwitz, B.3
Manrique, A.4
Kuster, H.5
Niederost, B.6
-
18
-
-
0025719309
-
Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41
-
Ebenbichler CF, Thielens NM, Vornhagen R, Marschang P, Arlaud GJ, Dierich MP. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J Exp Med 1991; 174: 1417-1424.
-
(1991)
J Exp Med
, vol.174
, pp. 1417-1424
-
-
Ebenbichler, C.F.1
Thielens, N.M.2
Vornhagen, R.3
Marschang, P.4
Arlaud, G.J.5
Dierich, M.P.6
-
19
-
-
0025880239
-
Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells
-
Spear GT, Jiang HX, Sullivan BL, Gewurz H, Landay AL, Lint TF. Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells. AIDS Res Hum Retroviruses 1991; 7: 579-585.
-
(1991)
AIDS Res Hum Retroviruses
, vol.7
, pp. 579-585
-
-
Spear, G.T.1
Jiang, H.X.2
Sullivan, B.L.3
Gewurz, H.4
Landay, A.L.5
Lint, T.F.6
-
20
-
-
0027372368
-
Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins
-
Haurum JS, Thiel S, Jones IM, Fischer PB, Laursen SB, Jensenius JC. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 1993; 7: 1307-1313.
-
(1993)
AIDS
, vol.7
, pp. 1307-1313
-
-
Haurum, J.S.1
Thiel, S.2
Jones, I.M.3
Fischer, P.B.4
Laursen, S.B.5
Jensenius, J.C.6
-
21
-
-
0027454001
-
Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1
-
Thielens NM, Bally IM, Ebenbichler CF, Dierich MP, Arlaud GJ. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1. J Immunol 1993; 151: 6583-6592. (Pubitemid 23340405)
-
(1993)
Journal of Immunology
, vol.151
, Issue.11
, pp. 6583-6592
-
-
Thielens, N.M.1
Bally, I.M.2
Ebenbichler, C.F.3
Dierich, M.P.4
Arlaud, G.J.5
-
22
-
-
0027791790
-
Interaction of C1 with HIV-1
-
Thielens NM, Bally IM, Ebenbichler CF, Dierich MP, Arlaud GJ. Interaction of C1 with HIV-1. Behring Inst Mitt 1993; (93): 165-170.
-
(1993)
Behring Inst Mitt
, Issue.93
, pp. 165-170
-
-
Thielens, N.M.1
Bally, I.M.2
Ebenbichler, C.F.3
Dierich, M.P.4
Arlaud, G.J.5
-
23
-
-
0027979727
-
The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology
-
Stoiber H, Thielens NM, Ebenbichler C, Arlaud GJ, Dierich MP. The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology. Eur J Immunol 1994; 24: 294-300.
-
(1994)
Eur J Immunol
, vol.24
, pp. 294-300
-
-
Stoiber, H.1
Thielens, N.M.2
Ebenbichler, C.3
Arlaud, G.J.4
Dierich, M.P.5
-
24
-
-
0028833387
-
Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1
-
Stoiber H, Ebenbichler C, Schneider R, Janatova J, Dierich MP. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS 1995; 9: 19-26.
-
(1995)
AIDS
, vol.9
, pp. 19-26
-
-
Stoiber, H.1
Ebenbichler, C.2
Schneider, R.3
Janatova, J.4
Dierich, M.P.5
-
25
-
-
0029869284
-
Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120
-
Susal C, Kirschfink M, Kropelin M, Daniel V, Opelz G. Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120. Blood 1996; 87: 2329-2336. (Pubitemid 26086874)
-
(1996)
Blood
, vol.87
, Issue.6
, pp. 2329-2336
-
-
Susal, C.1
Kirschfink, M.2
Kropelin, M.3
Daniel, V.4
Opelz, G.5
-
26
-
-
13944279109
-
Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection
-
DOI 10.1128/JVI.79.5.2823-2830.2005
-
Aasa-Chapman MM, Holuigue S, Aubin K, Wong M, Jones NA, Cornforth D et al. Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. J Virol 2005; 79: 2823-2830. (Pubitemid 40270560)
-
(2005)
Journal of Virology
, vol.79
, Issue.5
, pp. 2823-2830
-
-
Aasa-Chapman, M.M.I.1
Holuigue, S.2
Aubin, K.3
Wong, M.4
Jones, N.A.5
Cornforth, D.6
Pellegrino, P.7
Newton, P.8
Williams, I.9
Borrow, P.10
McKnight, A.11
-
27
-
-
0030586652
-
Susceptibility of HIV-1 Plasma Virus to Complement-Mediated Lysis: Evidence for a Role in Clearance of Virus in Vivo
-
Sullivan BL, Knopoff EJ, Saifuddin M, Takefman DM, Saarloos MN, Sha BE et al. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. J Immunol 1996; 157: 1791-1798. (Pubitemid 126449124)
-
(1996)
Journal of Immunology
, vol.157
, Issue.4
, pp. 1791-1798
-
-
Sullivan, B.L.1
Knopoff, E.J.2
Saifuddin, M.3
Takefman, D.M.4
Saarloos, M.-N.5
Sha, B.E.6
Spear, G.T.7
-
28
-
-
0032168058
-
Complement can neutralizeHIV-1 plasma virus by a C5-independent mechanism
-
Sullivan BL, Takefman DM, Spear GT. Complement can neutralizeHIV-1 plasma virus by a C5-independent mechanism. Virology 1998; 248: 173-181.
-
(1998)
Virology
, vol.248
, pp. 173-181
-
-
Sullivan, B.L.1
Takefman, D.M.2
Spear, G.T.3
-
29
-
-
0026970210
-
Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis
-
Posner MR, Elboim HS, Cannon T, Cavacini L, Hideshima T. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis. AIDS Res Hum Retroviruses 1992; 8: 553-558. (Pubitemid 23130907)
-
(1992)
AIDS Research and Human Retroviruses
, vol.8
, Issue.5
, pp. 553-558
-
-
Posner, M.R.1
Elboim, H.S.2
Cannon, T.3
Cavacini, L.4
Hideshima, T.5
-
30
-
-
0031449456
-
Passive immunization with a human monoclonal antibody protects hu-PBL- SCID mice against challenge by primary isolates of HIV-1
-
DOI 10.1038/nm1297-1389
-
Gauduin MC, Parren PW, Weir R, Barbas CF, Burton DR, Koup RA. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat Med 1997; 3: 1389-1393. (Pubitemid 28011040)
-
(1997)
Nature Medicine
, vol.3
, Issue.12
, pp. 1389-1393
-
-
Gauduin, M.-C.1
Parren, P.W.H.I.2
Weir, R.3
Barbas, C.F.4
Burton, D.R.5
Koup, R.A.6
-
31
-
-
0029162867
-
Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CE59 in complement resistance of cell derived and primary isolates of HIV-1
-
Saifuddin M, Parker CJ, Peeples ME, Gorny MK, Zolla-Pazner S, Ghassemi M et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CE59 in complement resistance of cell derived and primary isolates of HIV-1. J Exp Med 1995; 182: 501-509.
-
(1995)
J Exp Med
, vol.182
, pp. 501-509
-
-
Saifuddin, M.1
Parker, C.J.2
Peeples, M.E.3
Gorny, M.K.4
Zolla-Pazner, S.5
Ghassemi, M.6
-
32
-
-
0029090040
-
Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59
-
Schmitz J, Zimmer JP, Kluxen B, Aries S, Bogel M, Gigli I et al. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59. J Clin Invest 1995; 96: 1520-1526.
-
(1995)
J Clin Invest
, vol.96
, pp. 1520-1526
-
-
Schmitz, J.1
Zimmer, J.P.2
Kluxen, B.3
Aries, S.4
Bogel, M.5
Gigli, I.6
-
34
-
-
34347214119
-
Humoral immunity to HIV-1: Neutralization and beyond
-
DOI 10.1111/j.1365-2796.2007.01819.x
-
Huber M, Trkola A. Humoral immunity to HIV-1: neutralization and beyond. J Intern Med 2007; 262: 5-25. (Pubitemid 47000630)
-
(2007)
Journal of Internal Medicine
, vol.262
, Issue.1
, pp. 5-25
-
-
Huber, M.1
Trkola, A.2
-
35
-
-
34347256384
-
Inhibition of HIV-1 entry by antibodies: Potential viral and cellular targets
-
DOI 10.1111/j.1365-2796.2007.01820.x
-
Phogat S, Wyatt RT, Karlsson Hedestam GB. Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets. J Intern Med 2007; 262: 26-43. (Pubitemid 47000631)
-
(2007)
Journal of Internal Medicine
, vol.262
, Issue.1
, pp. 26-43
-
-
Phogat, S.1
Wyatt, R.T.2
Karlsson, H.G.B.3
-
36
-
-
34250323791
-
HIV-1 rational vaccine design: Molecular details of b12-gp120 complex structure
-
DOI 10.1586/14760584.6.3.319
-
Phogat SK, Kaminsky SM, Koff WC. HIV-1 rational vaccine design: molecular details of b12-gp120 complex structure. Expert Rev Vaccines 2007; 6: 319-321. (Pubitemid 46911595)
-
(2007)
Expert Review of Vaccines
, vol.6
, Issue.3
, pp. 319-321
-
-
Phogat, S.K.1
Kaminsky, S.M.2
Koff, W.C.3
-
37
-
-
56649083541
-
Humoral immunity to HIV-1: Neutralisation and antibody effector functions
-
Willey S, Aasa-Chapman MM. Humoral immunity to HIV-1: neutralisation and antibody effector functions. Trends Microbiol 2008; 16: 596-604.
-
(2008)
Trends Microbiol
, vol.16
, pp. 596-604
-
-
Willey, S.1
Aasa-Chapman, M.M.2
-
38
-
-
42049085289
-
Correlates of antibody-mediated protection against HIV infection
-
DOI 10.1097/COH.0b013e3282f9ae79, PII 0122292920080500000027
-
Sattentau Q. Correlates of antibody-mediated protection against HIV infection. Curr Opin HIV AIDS 2008; 3: 368-374. (Pubitemid 351521023)
-
(2008)
Current Opinion in HIV and AIDS
, vol.3
, Issue.3
, pp. 368-374
-
-
Sattentau, Q.1
-
39
-
-
0032546844
-
The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
-
DOI 10.1126/science.280.5371.1884
-
Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998; 280: 1884-1888. (Pubitemid 28299385)
-
(1998)
Science
, vol.280
, Issue.5371
, pp. 1884-1888
-
-
Wyatt, R.1
Sodroski, J.2
-
40
-
-
0035222608
-
The antiviral activity of antibodies in vitro and in vivo
-
DOI 10.1016/S0065-2776(01)77018-6
-
Parren PW, Burton DR. The antiviral activity of antibodies in vitro and in vivo. Adv Immunol 2001; 77: 195-262. (Pubitemid 33703707)
-
(2001)
Advances in Immunology
, vol.77
, pp. 195-262
-
-
Parren, P.W.H.I.1
Burton, D.R.2
-
41
-
-
0036436313
-
Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies
-
DOI 10.1089/08892220260387959
-
Xiang SH, Doka N, Choudhary RK, Sodroski J, Robinson JE. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. AIDS Res Hum Retroviruses 2002; 18: 1207-1217. (Pubitemid 35370609)
-
(2002)
AIDS Research and Human Retroviruses
, vol.18
, Issue.16
, pp. 1207-1217
-
-
Xiang, S.-H.1
Doka, N.2
Choudhary, R.K.3
Sodroski, J.4
Robinson, J.E.5
-
42
-
-
20844448731
-
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
-
DOI 10.1084/jem.20042510
-
Decker JM, Bibollet-Ruche F, Wei X, Wang S, Levy DN, Wang W et al. Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med 2005; 201: 1407-1419. (Pubitemid 40664085)
-
(2005)
Journal of Experimental Medicine
, vol.201
, Issue.9
, pp. 1407-1419
-
-
Decker, J.M.1
Bibollet-Ruche, F.2
Wei, X.3
Wang, S.4
Levy, D.N.5
Wang, W.6
Delaporte, E.7
Peeters, M.8
Derdeyn, C.A.9
Allen, S.10
Hunter, E.11
Saag, M.S.12
Hoxie, J.A.13
Hahn, B.H.14
Kwong, P.D.15
Robinson, J.E.16
Shaw, G.M.17
-
43
-
-
16144365317
-
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co- Receptor CCR-5
-
DOI 10.1038/384184a0
-
Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996; 384: 184-187. (Pubitemid 26386476)
-
(1996)
Nature
, vol.384
, Issue.6605
, pp. 184-187
-
-
Trkola, A.1
Dragic, T.2
Arthos, J.3
Binley, J.M.4
Olson, W.C.5
Allaway, G.P.6
Cheng-, M.C.7
Robinson, J.8
Maddon, P.J.9
Moore, J.P.10
-
44
-
-
16144365650
-
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
-
DOI 10.1038/384179a0
-
Wu L, Gerard NP, Wyatt R, ChoeH, Parolin C, Ruffing N et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996; 384: 179-183. (Pubitemid 26386475)
-
(1996)
Nature
, vol.384
, Issue.6605
, pp. 179-183
-
-
Wu, L.1
Gerard, N.P.2
Wyatt, R.3
Choe, H.4
Parolin, C.5
Ruffing, N.6
Borsetti, A.7
Cardoso, A.A.8
Desjardin, E.9
Newman, W.10
Gerard, C.11
Sodroski, J.12
-
45
-
-
33646146379
-
GP120: Target for neutralizing HIV-1 antibodies
-
Pantophlet R, Burton DR. GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 2006; 24: 739-769.
-
(2006)
Annu Rev Immunol
, vol.24
, pp. 739-769
-
-
Pantophlet, R.1
Burton, D.R.2
-
46
-
-
0035991710
-
Neutralizing antibody responses to HIV-1 infection
-
DOI 10.1080/15216540212656
-
Morris L. Neutralizing antibody responses to HIV-1 infection. IUBMB Life 2002; 53: 197-199. (Pubitemid 34728926)
-
(2002)
IUBMB Life
, vol.53
, Issue.4-5
, pp. 197-199
-
-
Morris, L.1
-
47
-
-
0028321596
-
Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers
-
Pincus SH, Messer KG, Nara PL, Blattner WA, Colclough G, Reitz M. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers. J Clin Invest 1994; 93: 2505-2513.
-
(1994)
J Clin Invest
, vol.93
, pp. 2505-2513
-
-
Pincus, S.H.1
Messer, K.G.2
Nara, P.L.3
Blattner, W.A.4
Colclough, G.5
Reitz, M.6
-
48
-
-
0029113691
-
Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection
-
Belec L, Dupre T, Prazuck T, Tevi-Benissan C, Kanga JM, Pathey O et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995; 172: 691-697.
-
(1995)
J Infect Dis
, vol.172
, pp. 691-697
-
-
Belec, L.1
Dupre, T.2
Prazuck, T.3
Tevi-Benissan, C.4
Kanga, J.M.5
Pathey, O.6
-
49
-
-
0030897105
-
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1
-
Binley JM, Klasse PJ, Cao Y, Jones I, Markowitz M, Ho DD et al. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol 1997; 71: 2799-2809. (Pubitemid 27119919)
-
(1997)
Journal of Virology
, vol.71
, Issue.4
, pp. 2799-2809
-
-
Binley, J.M.1
Klasse, P.J.2
Cao, Y.3
Jones, I.4
Markowitz, M.5
Ho, D.D.6
Moore, J.P.7
-
50
-
-
0029981354
-
Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads
-
Pellegrin I, Legrand E, Neau D, Bonot P, Masquelier B, Pellegrin JL et al. Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11: 438-447. (Pubitemid 26135080)
-
(1996)
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
, vol.11
, Issue.5
, pp. 438-447
-
-
Pellegrin, I.1
Legrand, E.2
Neau, D.3
Bonot, P.4
Masquelier, B.5
Pellegrin, J.-L.6
Ragnaud, J.-M.7
Bernard, N.8
Fleury, H.J.A.9
-
51
-
-
0037389643
-
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
-
DOI 10.1073/pnas.0630530100
-
Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003; 100: 4144-4149. (Pubitemid 36418171)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.7
, pp. 4144-4149
-
-
Richman, D.D.1
Wrin, T.2
Little, S.J.3
Petropoulos, C.J.4
-
52
-
-
1642373711
-
Development of the antibody response in acute HIV-1 infection
-
DOI 10.1097/00002030-200402200-00002
-
Aasa-Chapman MM, Hayman A, Newton P, Cornforth D, Williams I, Borrow P et al. Development of the antibody response in acute HIV-1 infection. AIDS 2004; 18: 371-381. (Pubitemid 38365863)
-
(2004)
AIDS
, vol.18
, Issue.3
, pp. 371-381
-
-
Aasa-Chapman, M.M.I.1
Hayman, A.2
Newton, P.3
Cornforth, D.4
Williams, I.5
Borrow, P.6
Balfe, P.7
McKnight, A.8
-
53
-
-
33745890578
-
The role of neutralizing antibodies in HIV infection
-
Humbert M, Dietrich U. The role of neutralizing antibodies in HIV infection. AIDS Rev 2006; 8: 51-59. (Pubitemid 44043554)
-
(2006)
AIDS Reviews
, vol.8
, Issue.2
, pp. 51-59
-
-
Humbert, M.1
Dietrich, U.2
-
54
-
-
0027378573
-
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
-
Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G et al. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 1993; 67: 6642-6647. (Pubitemid 23309131)
-
(1993)
Journal of Virology
, vol.67
, Issue.11
, pp. 6642-6647
-
-
Muster, T.1
Steindl, F.2
Purtscher, M.3
Trkola, A.4
Klima, A.5
Himmler, G.6
Ruker, F.7
Katinger, H.8
-
55
-
-
0027985431
-
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
-
Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, Parren PW et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 1994; 266: 1024-1027. (Pubitemid 24373715)
-
(1994)
Science
, vol.266
, Issue.5187
, pp. 1024-1027
-
-
Burton, D.R.1
Pyati, J.2
Koduri, R.3
Sharp, S.J.4
Thornton, G.B.5
Parren, P.W.H.I.6
Sawyer, L.S.W.7
Hendry, R.M.8
Dunlop, N.9
Nara, P.L.10
Lamacchia, M.11
Garratty, E.12
Stiehm, E.R.13
Bryson, Y.J.14
Cao, Y.15
Moore, J.P.16
Ho, D.D.17
Barbas III, C.F.18
-
56
-
-
8644251891
-
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
-
DOI 10.1128/JVI.78.23.13232-13252.2004
-
Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C et al. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 2004; 78: 13232-13252. (Pubitemid 39507829)
-
(2004)
Journal of Virology
, vol.78
, Issue.23
, pp. 13232-13252
-
-
Binley, J.M.1
Wrin, T.2
Korber, B.3
Zwick, M.B.4
Wang, M.5
Chappey, C.6
Stiegler, G.7
Kunert, R.8
Zolla-Pazner, S.9
Katinger, H.10
Petropoulos, C.J.11
Burton, D.R.12
-
57
-
-
0034759882
-
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
-
DOI 10.1128/JVI.75.22.10892-10905.2001
-
Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM et al. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 2001; 75: 10892-10905. (Pubitemid 33034579)
-
(2001)
Journal of Virology
, vol.75
, Issue.22
, pp. 10892-10905
-
-
Zwick, M.B.1
Labrijn, A.F.2
Wang, M.3
Spenlehauer, C.4
Ollmann, S.E.5
Binley, J.M.6
Moore, J.P.7
Stiegler, G.8
Katinger, H.9
Burton, D.R.10
Parren, P.W.H.I.11
-
58
-
-
0035701421
-
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
-
DOI 10.1089/08892220152741450
-
Stiegler G, Kunert R, Purtscher M, Wolbank S, Voglauer R, Steindl F et al. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 2001; 17: 1757-1765. (Pubitemid 34114213)
-
(2001)
AIDS Research and Human Retroviruses
, vol.17
, Issue.18
, pp. 1757-1765
-
-
Stiegler, G.1
Kunert, R.2
Purtscher, M.3
Wolbank, S.4
Voglauer, R.5
Steindl, F.6
Katinger, H.7
-
59
-
-
0028235930
-
Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS
-
Muster T, Guinea R, Trkola A, Purtscher M, Klima A, Steindl F et al. Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. J Virol 1994; 68: 4031-4034. (Pubitemid 24177431)
-
(1994)
Journal of Virology
, vol.68
, Issue.6
, pp. 4031-4034
-
-
Muster, T.1
Guinea, R.2
Trkola, A.3
Purtscher, M.4
Klima, A.5
Steindl, F.6
Palese, P.7
Katinger, H.8
-
60
-
-
0028593629
-
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1
-
Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F et al. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994; 10: 1651-1658.
-
(1994)
AIDS Res Hum Retroviruses
, vol.10
, pp. 1651-1658
-
-
Purtscher, M.1
Trkola, A.2
Gruber, G.3
Buchacher, A.4
Predl, R.5
Steindl, F.6
-
61
-
-
9044241681
-
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
-
Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 1996; 70: 1100-1108. (Pubitemid 26029030)
-
(1996)
Journal of Virology
, vol.70
, Issue.2
, pp. 1100-1108
-
-
Trkola, A.1
Purtscher, M.2
Muster, T.3
Ballaun, C.4
Buchacher, A.5
Sullivan, N.6
Srinivasan, K.7
Sodroski, J.8
Moore, J.P.9
Katinger, H.10
-
62
-
-
0028291731
-
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1
-
Roben P, Moore JP, Thali M, Sodroski J, Barbas CF 3rd, Burton DR. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J Virol 1994; 68: 4821-4828. (Pubitemid 24226546)
-
(1994)
Journal of Virology
, vol.68
, Issue.8
, pp. 4821-4828
-
-
Roben, P.1
Moore, J.P.2
Thali, M.3
Sodroski, J.4
Barbas III, C.F.5
Burton, D.R.6
-
63
-
-
27944455654
-
HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: In vitro experiments versus clinical studies
-
Nakowitsch S, Quendler H, Fekete H, Kunert R, Katinger H, Stiegler G. HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies. AIDS 2005; 19: 1957-1966. (Pubitemid 41669019)
-
(2005)
AIDS
, vol.19
, Issue.17
, pp. 1957-1966
-
-
Nakowitsch, S.1
Quendler, H.2
Fekete, H.3
Kunert, R.4
Katinger, H.5
Stiegler, G.6
-
64
-
-
34547808791
-
In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10
-
Manrique A, Rusert P, Joos B, Fischer M, Kuster H, Leemann C et al. In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10. J Virol 2007; 81: 8793-8808.
-
(2007)
J Virol
, vol.81
, pp. 8793-8808
-
-
Manrique, A.1
Rusert, P.2
Joos, B.3
Fischer, M.4
Kuster, H.5
Leemann, C.6
-
65
-
-
18244422922
-
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1->2 mannose residues on the outer face of gp120
-
Scanlan CN, Pantophlet R, Wormald MR, Ollmann Saphire E, Stanfield R, Wilson IA et al. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1->2 mannose residues on the outer face of gp120. J Virol 2002; 76: 7306-7321.
-
(2002)
J Virol
, vol.76
, pp. 7306-7321
-
-
Scanlan, C.N.1
Pantophlet, R.2
Wormald, M.R.3
Ollmann Saphire, E.4
Stanfield, R.5
Wilson, I.A.6
-
66
-
-
26444450696
-
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12
-
DOI 10.1073/pnas.0505763102
-
Calarese DA, Lee HK, Huang CY, Best MD, Astronomo RD, Stanfield RL et al. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci USA 2005; 102: 13372-13377. (Pubitemid 41420854)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.38
, pp. 13372-13377
-
-
Calarese, D.A.1
Lee, H.-K.2
Huang, C.-Y.3
Best, M.D.4
Astronomo, R.D.5
Stanfield, R.L.6
Katinger, H.7
Burton, D.R.8
Wong, C.-H.9
Wilson, I.A.10
-
68
-
-
13844255333
-
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
-
DOI 10.1016/j.immuni.2004.12.011
-
Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H et al. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 2005; 22: 163-173. (Pubitemid 40255708)
-
(2005)
Immunity
, vol.22
, Issue.2
, pp. 163-173
-
-
Cardoso, R.M.F.1
Zwick, M.B.2
Stanfield, R.L.3
Kunert, R.4
Binley, J.M.5
Katinger, H.6
Burton, D.R.7
Wilson, I.A.8
-
69
-
-
0033951746
-
Protection of macaques against vaginal transmission of a pathogenic HIV- 1/SIV chimeric virus by passive infusion of neutralizing antibodies
-
DOI 10.1038/72318
-
Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000; 6: 207-210. (Pubitemid 30082367)
-
(2000)
Nature Medicine
, vol.6
, Issue.2
, pp. 207-210
-
-
Mascola, J.R.1
Stiegler, G.2
Vancott, T.C.3
Katinger, H.4
Carpenter, C.B.5
Hanson, C.E.6
Beary, H.7
Hayes, D.8
Frankel, S.S.9
Birx, D.L.10
Lewis, M.G.11
-
70
-
-
0032947286
-
Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
-
Mascola JR, Lewis MG, Stiegler G, Harris D, VanCott TC, Hayes D et al. Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol 1999; 73: 4009-4018. (Pubitemid 29189846)
-
(1999)
Journal of Virology
, vol.73
, Issue.5
, pp. 4009-4018
-
-
Mascola, J.R.1
Lewis, M.G.2
Stiegler, G.3
Harris, D.4
Vancott, T.C.5
Hayes, D.6
Louder, M.K.7
Brown, C.R.8
Sapan, C.V.9
Frankel, S.S.10
Lu, Y.11
Robb, M.L.12
Katinger, H.13
Birx, D.L.14
-
71
-
-
0033952103
-
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
-
DOI 10.1038/72309
-
Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000; 6: 200-206. (Pubitemid 30082366)
-
(2000)
Nature Medicine
, vol.6
, Issue.2
, pp. 200-206
-
-
Baba, T.W.1
Liska, V.2
Hofmann-Lehmann, R.3
Vlasak, J.4
Xu, W.5
Ayehunie, S.6
Cavacini, L.A.7
Posner, M.R.8
Katinger, H.9
Stiegler, G.10
Bernacky, B.J.11
Rizvi, T.A.12
Schmidt, R.13
Hill, L.R.14
Keeling, M.E.15
Lu, Y.16
Wright, J.E.17
Chou, T.-C.18
Ruprecht, R.M.19
-
72
-
-
20944446452
-
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
-
Trkola A, Kuster H, Rusert P, Joos B, Fischer M, Leemann C et al. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat Med 2005; 11: 615-622.
-
(2005)
Nat Med
, vol.11
, pp. 615-622
-
-
Trkola, A.1
Kuster, H.2
Rusert, P.3
Joos, B.4
Fischer, M.5
Leemann, C.6
-
73
-
-
0000604395
-
The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity
-
Parren PW, Moore JP, Burton DR, Sattentau QJ. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS 1999; 13(Suppl A): S137-S162.
-
(1999)
AIDS
, vol.13
, Issue.SUPPL. A
-
-
Parren, P.W.1
Moore, J.P.2
Burton, D.R.3
Sattentau, Q.J.4
-
74
-
-
57649237596
-
Complement and antibodies: A dangerous liaison in HIV infection?
-
Stoiber H, Soederholm A, Wilflingseder D, Gusenbauer S, Hildgartner A, Dierich MP. Complement and antibodies: a dangerous liaison in HIV infection? Vaccine 2008; 26(Suppl 8): I79-I85.
-
(2008)
Vaccine
, vol.26
, Issue.SUPPL. 8
-
-
Stoiber, H.1
Soederholm, A.2
Wilflingseder, D.3
Gusenbauer, S.4
Hildgartner, A.5
Dierich, M.P.6
-
75
-
-
0037456827
-
Antibody neutralization and escape by HIV-1
-
DOI 10.1038/nature01470
-
Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X et al. Antibody neutralization and escape by HIV-1. Nature 2003; 422: 307-312. (Pubitemid 36378357)
-
(2003)
Nature
, vol.422
, Issue.6929
, pp. 307-312
-
-
Wei, X.1
Decker, J.M.2
Wang, S.3
Hui, H.4
Kappes, J.C.5
Wu, X.6
Salazar-Gonzalez, J.F.7
Salazar, M.G.8
Kilby, J.M.9
Saag, M.S.10
Komarova, N.L.11
Nowak, M.A.12
Hahn, B.H.13
Kwong, P.D.14
Shaw, G.M.15
-
77
-
-
33745203490
-
Distribution and three-dimensional structure of AIDS virus envelope spikes
-
Zhu P, Liu J, Bess J Jr, Chertova E, Lifson JD, Grise H et al. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 2006; 441: 847-852.
-
(2006)
Nature
, vol.441
, pp. 847-852
-
-
Zhu, P.1
Liu, J.2
Bess Jr., J.3
Chertova, E.4
Lifson, J.D.5
Grise, H.6
-
78
-
-
0025572710
-
Dissociation of gp120 from HIV-1 virions induced by soluble CD4
-
Moore JP, McKeating JA, Weiss RA, Sattentau QJ. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 1990; 250: 1139-1142. (Pubitemid 120031823)
-
(1990)
Science
, vol.250
, Issue.4984
, pp. 1139-1142
-
-
Moore, J.P.1
Mckeating, J.A.2
Weiss, R.A.3
Sattentau, Q.J.4
-
79
-
-
0026098303
-
Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: Effects on infectivity and neutralization
-
McKeating JA, McKnight A, Moore JP. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J Virol 1991; 65: 852-860.
-
(1991)
J Virol
, vol.65
, pp. 852-860
-
-
McKeating, J.A.1
McKnight, A.2
Moore, J.P.3
-
80
-
-
0037213278
-
Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies
-
DOI 10.1128/JVI.77.1.353-365.2003
-
Poignard P, Moulard M, Golez E, Vivona V, Franti M, Venturini S et al. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies. J Virol 2003; 77: 353-365. (Pubitemid 36004975)
-
(2003)
Journal of Virology
, vol.77
, Issue.1
, pp. 353-365
-
-
Poignard, P.1
Moulard, M.2
Golez, E.3
Vivona, V.4
Franti, M.5
Venturini, S.6
Wang, M.7
Parren, P.W.H.I.8
Burton, D.R.9
-
81
-
-
1842613542
-
HIV-1 dynamics in vivo: Implications for therapy
-
Simon V, Ho DD. HIV-1 dynamics in vivo: implications for therapy. Nat Rev Microbiol 2003; 1: 181-190.
-
(2003)
Nat Rev Microbiol
, vol.1
, pp. 181-190
-
-
Simon, V.1
Ho, D.D.2
-
82
-
-
52949114578
-
Identifying the important HIV-1 recombination breakpoints
-
Archer J, Pinney JW, Fan J, Simon-Loriere E, Arts EJ, Negroni M et al. Identifying the important HIV-1 recombination breakpoints. PLoS Comput Biol 2008; 4: e1000178.
-
(2008)
PLoS Comput Biol
, vol.4
-
-
Archer, J.1
Pinney, J.W.2
Fan, J.3
Simon-Loriere, E.4
Arts, E.J.5
Negroni, M.6
-
83
-
-
33750297873
-
HIV evolutionary dynamics within and among hosts
-
Lemey P, Rambaut A, Pybus OG. HIV evolutionary dynamics within and among hosts. AIDS Rev 2006; 8: 125-140. (Pubitemid 44614030)
-
(2006)
AIDS Reviews
, vol.8
, Issue.3
, pp. 125-140
-
-
Lemey, P.1
Rambaut, A.2
Pybus, O.G.3
-
84
-
-
33746898165
-
Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread
-
DOI 10.1084/jem.20051557
-
Hangartner L, Zellweger RM, Giobbi M, Weber J, Eschli B, McCoy KD et al. Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread. J Exp Med 2006; 203: 2033-2042. (Pubitemid 44188476)
-
(2006)
Journal of Experimental Medicine
, vol.203
, Issue.8
, pp. 2033-2042
-
-
Hangartner, L.1
Zellweger, R.M.2
Giobbi, M.3
Weber, J.4
Eschli, B.5
McCoy, K.D.6
Harris, N.7
Recher, M.8
Zinkernagel, R.M.9
Hengartner, H.10
-
85
-
-
63849116536
-
Mechanisms of protection against rotavirus infection and disease
-
Ward R. Mechanisms of protection against rotavirus infection and disease. Pediatr Infect Dis J 2009; 28: S57-59.
-
(2009)
Pediatr Infect Dis J
, vol.28
-
-
Ward, R.1
-
86
-
-
0021246636
-
Monoclonal antibodies protect against respiratory syncytial virus infection in mice
-
Taylor G, Stott EJ, Bew M, Fernie BF, Cote PJ, Collins AP et al. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 1984; 52: 137-142. (Pubitemid 14136692)
-
(1984)
Immunology
, vol.52
, Issue.1
, pp. 137-142
-
-
Taylor, G.1
Stott, E.J.2
Bew, M.3
-
87
-
-
0024449532
-
Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins
-
Walsh EE, Hall CB, Schlesinger JJ, Brandriss MW, Hildreth S, Paradiso P. Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins. J Gen Virol 1989; 70(Pt 11): 2953-2961. (Pubitemid 19283614)
-
(1989)
Journal of General Virology
, vol.70
, Issue.11
, pp. 2953-2961
-
-
Walsh, E.E.1
Hall, C.B.2
Schlesinger, J.J.3
Brandriss, M.W.4
Hildreth, S.5
Paradiso, P.6
-
88
-
-
33646163652
-
A review of vaccine research and development: The human immunodeficiency virus (HIV)
-
Girard MP, Osmanov SK, Kieny MP. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 2006; 24: 4062-4081.
-
(2006)
Vaccine
, vol.24
, pp. 4062-4081
-
-
Girard, M.P.1
Osmanov, S.K.2
Kieny, M.P.3
-
89
-
-
52449104809
-
DNA vaccines: Ready for prime time?
-
Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat Rev Genet 2008; 9: 776-788.
-
(2008)
Nat Rev Genet
, vol.9
, pp. 776-788
-
-
Kutzler, M.A.1
Weiner, D.B.2
-
90
-
-
56149095844
-
Immunogenicity of DNA vaccines in humans: It takes two to tango
-
Lu S. Immunogenicity of DNA vaccines in humans: it takes two to tango. Hum Vaccin 2008; 4: 449-452.
-
(2008)
Hum Vaccin
, vol.4
, pp. 449-452
-
-
Lu, S.1
-
91
-
-
36148973173
-
HIV/AIDS vaccines: 2007
-
Robinson HL. HIV/AIDS vaccines: 2007. Clin Pharmacol Ther 2007; 82: 686-693.
-
(2007)
Clin Pharmacol Ther
, vol.82
, pp. 686-693
-
-
Robinson, H.L.1
-
92
-
-
42049083555
-
T cell responses generated by HIV vaccines in clinical trials
-
DOI 10.1097/COH.0b013e3282fbaaa7, PII 0122292920080500000028
-
De Rosa SD, McElrath MJ. T cell responses generated by HIV vaccines in clinical trials. Curr Opin HIV AIDS 2008; 3: 375-379. (Pubitemid 351521024)
-
(2008)
Current Opinion in HIV and AIDS
, vol.3
, Issue.3
, pp. 375-379
-
-
De, R.S.D.1
McElrath, M.J.2
-
93
-
-
0037404791
-
Live recombinant vectors for AIDS vaccine development
-
DOI 10.2174/1566524033479816
-
Voltan R, Robert-Guroff M. Live recombinant vectors for AIDS vaccine development. Curr Mol Med 2003; 3: 273-284. (Pubitemid 36443225)
-
(2003)
Current Molecular Medicine
, vol.3
, Issue.3
, pp. 273-284
-
-
Voltan, R.1
Robert-Guroff, M.2
-
94
-
-
0036787478
-
A new generation of HIV vaccines
-
Amara RR, Robinson HL. A new generation of HIV vaccines. Trends Mol Med 2002; 8: 489-495.
-
(2002)
Trends Mol Med
, vol.8
, pp. 489-495
-
-
Amara, R.R.1
Robinson, H.L.2
-
95
-
-
48149108390
-
Designing an effective AIDS vaccine: Strategies and current status
-
French
-
Coutsinos Z, Absi Z, Henin Y, Guillet JG, Launay O. Designing an effective AIDS vaccine: strategies and current status. Rev Med Interne 2008; 29: 632-641. French
-
(2008)
Rev Med Interne
, vol.29
, pp. 632-641
-
-
Coutsinos, Z.1
Absi, Z.2
Henin, Y.3
Guillet, J.G.4
Launay, O.5
-
96
-
-
33746192136
-
HIV/AIDS preventive vaccine 'prime-boost' phase III trial: Foundations and initial lessons learned from Thailand
-
Rerks-Ngarm S, Brown AE, Khamboonruang C, Thongcharoen P, Kunasol P. HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand. AIDS 2006; 20: 1471-1479.
-
(2006)
AIDS
, vol.20
, pp. 1471-1479
-
-
Rerks-Ngarm, S.1
Brown, A.E.2
Khamboonruang, C.3
Thongcharoen, P.4
Kunasol, P.5
-
97
-
-
14544290129
-
Progress toward an HIV vaccine
-
DOI 10.1146/annurev.med.54.101601.152349
-
Letvin NL. Progress toward an HIV vaccine. Annu Rev Med 2005; 56: 213-223. (Pubitemid 40299781)
-
(2005)
Annual Review of Medicine
, vol.56
, pp. 213-223
-
-
Letvin, N.L.1
-
98
-
-
44049108744
-
Toward an AIDS vaccine
-
DOI 10.1126/science.1152622
-
Walker BD, Burton DR. Toward an AIDS vaccine. Science 2008; 320: 760-764. (Pubitemid 351929619)
-
(2008)
Science
, vol.320
, Issue.5877
, pp. 760-764
-
-
Walker, B.D.1
Burton, D.R.2
-
99
-
-
62249095476
-
The challenge of finding a cure for HIV infection
-
Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science 2009; 323: 1304-1307.
-
(2009)
Science
, vol.323
, pp. 1304-1307
-
-
Richman, D.D.1
Margolis, D.M.2
Delaney, M.3
Greene, W.C.4
Hazuda, D.5
Pomerantz, R.J.6
-
100
-
-
69149083668
-
Neutralizing antibodies generated during natural HIV-1 infection: Good news for an HIV-1 vaccine?
-
Stamatatos L, Morris L, Burton DR, Mascola JR. Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med 2009; 15: 866-870.
-
(2009)
Nat Med
, vol.15
, pp. 866-870
-
-
Stamatatos, L.1
Morris, L.2
Burton, D.R.3
Mascola, J.R.4
-
101
-
-
70349887757
-
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
-
Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009; 326: 285-289.
-
(2009)
Science
, vol.326
, pp. 285-289
-
-
Walker, L.M.1
Phogat, S.K.2
Chan-Hui, P.Y.3
Wagner, D.4
Phung, P.5
Goss, J.L.6
-
102
-
-
5444248711
-
Mannose binding lectin (MBL) and HIV
-
Ji X, Gewurz H, Spear GT. Mannose binding lectin (MBL) and HIV. Mol Immunol 2005; 42: 145-152.
-
(2005)
Mol Immunol
, vol.42
, pp. 145-152
-
-
Ji, X.1
Gewurz, H.2
Spear, G.T.3
-
103
-
-
0024584844
-
A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus
-
DOI 10.1084/jem.169.1.185
-
Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 1989; 169: 185-196. (Pubitemid 19035551)
-
(1989)
Journal of Experimental Medicine
, vol.169
, Issue.1
, pp. 185-196
-
-
Ezekowitz, R.A.B.1
Kuhlman, M.2
Groopman, J.E.3
Byrn, R.A.4
-
104
-
-
0034028110
-
Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1
-
Saifuddin M, Hart ML, Gewurz H, Zhang Y, Spear GT. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol 2000; 81: 949-955. (Pubitemid 30189633)
-
(2000)
Journal of General Virology
, vol.81
, Issue.4
, pp. 949-955
-
-
Saifuddin, M.1
Hart, M.L.2
Gewurz, H.3
Zhang, Y.4
Spear, G.T.5
-
105
-
-
1842450254
-
Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization
-
DOI 10.1089/088922204322996563
-
Ying H, Ji X, Hart ML, Gupta K, Saifuddin M, Zariffard MR et al. Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res Hum Retroviruses 2004; 20: 327-335. (Pubitemid 38429405)
-
(2004)
AIDS Research and Human Retroviruses
, vol.20
, Issue.3
, pp. 327-335
-
-
Ying, H.1
Ji, X.2
Hart, M.L.3
Gupta, K.4
Saifuddin, M.5
Zariffard, M.R.6
Spear, G.T.7
-
106
-
-
0037311412
-
Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin
-
DOI 10.1099/vir.0.18734-0
-
Hart ML, Saifuddin M, Spear GT. Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin. J Gen Virol 2003; 84: 353-360. (Pubitemid 36175709)
-
(2003)
Journal of General Virology
, vol.84
, Issue.2
, pp. 353-360
-
-
Hart, M.L.1
Saifuddin, M.2
Spear, G.T.3
-
107
-
-
46049088698
-
An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children
-
Singh KK, Lieser A, Ruan PK, Fenton T, Spector SA. An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children. J Allergy Clin Immunol 2008; 122: 173-180, 180.e1-2.
-
(2008)
J Allergy Clin Immunol
, vol.122
-
-
Singh, K.K.1
Lieser, A.2
Ruan, P.K.3
Fenton, T.4
Spector, S.A.5
-
108
-
-
70450225061
-
Association between mannose-binding lectin and HIV infection and progression in a Chinese population
-
Tan Y, Liu L, Luo P, Wang A, Jia T, Shen X et al. Association between mannose-binding lectin and HIV infection and progression in a Chinese population. Mol Immunol 2009; 47: 632-638.
-
(2009)
Mol Immunol
, vol.47
, pp. 632-638
-
-
Tan, Y.1
Liu, L.2
Luo, P.3
Wang, A.4
Jia, T.5
Shen, X.6
-
109
-
-
26044449325
-
C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells
-
DOI 10.1002/eji.200425940
-
Pruenster M, Wilflingseder D, Banki Z, Ammann CG, Muellauer B, Meyer M et al. Ctype lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells. Eur J Immunol 2005; 35: 2691-2698. (Pubitemid 41404052)
-
(2005)
European Journal of Immunology
, vol.35
, Issue.9
, pp. 2691-2698
-
-
Pruenster, M.1
Wilflingseder, D.2
Banki, Z.3
Ammann, C.G.4
Muellauer, B.5
Meyer, M.6
Speth, C.7
Dierich, M.P.8
Stoiber, H.9
-
110
-
-
6344261596
-
Cutting edge: Productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18)
-
Bajtay Z, Speth C, Erdei A, Dierich MP. Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18). J Immunol 2004; 173: 4775-4778. (Pubitemid 39387756)
-
(2004)
Journal of Immunology
, vol.173
, Issue.8
, pp. 4775-4778
-
-
Bajtay, Z.1
Speth, C.2
Erdei, A.3
Dierich, M.P.4
-
111
-
-
0031305498
-
Complement-mediated enhancement of HIV-1 infection in peripheral blood mononuclear cells
-
Nielsen SD, Sorensen AM, Schonning K, Lund O, Nielsen JO, Hansen JE. Complement-mediated enhancement of HIV-1 infection in peripheral blood mononuclear cells. Scand J Infect Dis 1997; 29: 447-452.
-
(1997)
Scand J Infect Dis
, vol.29
, pp. 447-452
-
-
Nielsen, S.D.1
Sorensen, A.M.2
Schonning, K.3
Lund, O.4
Nielsen, J.O.5
Hansen, J.E.6
-
112
-
-
8244253673
-
Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection
-
DOI 10.1097/00002030-199708000-00002
-
Prohaszka Z, Nemes J, Hidvegi T, Toth FD, Kerekes K, Erdei A et al. Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection. AIDS 1997; 11: 949-958. (Pubitemid 27259516)
-
(1997)
AIDS
, vol.11
, Issue.8
, pp. 949-958
-
-
Prohaszka, Z.1
Nemes, J.2
Hidvegi, T.3
Toth, F.D.4
Kerekes, K.5
Erdei, A.6
Szabo, J.7
Ujhelyi, E.8
Thielens, N.9
Dierich, M.P.10
Spath, P.11
Ghebrehiwet, B.12
Hampl, H.13
Kiss, J.14
Arlaud, G.15
Fust, G.16
-
113
-
-
0025076044
-
Human leukocyte C1q receptor binds other soluble proteins with collagen domains
-
DOI 10.1084/jem.172.3.955
-
Malhotra R, Thiel S, Reid KB, Sim RB. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med 1990; 172: 955-959. (Pubitemid 20301242)
-
(1990)
Journal of Experimental Medicine
, vol.172
, Issue.3
, pp. 955-959
-
-
Malhotra, R.1
Thiel, S.2
Reid, K.B.M.3
Sim, R.B.4
-
114
-
-
0027200478
-
Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV
-
Delibrias CC, Kazatchkine MD, Fischer E. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand J Immunol 1993; 38: 183-189. (Pubitemid 23233545)
-
(1993)
Scandinavian Journal of Immunology
, vol.38
, Issue.2
, pp. 183-189
-
-
Delibrias, C.-C.1
Kazatchkine, M.D.2
Fischer, E.3
-
115
-
-
0028916065
-
Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection
-
Lund O, Hansen J, Soorensen AM, Mosekilde E, Nielsen JO, Hansen JE. Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection. J Virol 1995; 69: 2393-2400.
-
(1995)
J Virol
, vol.69
, pp. 2393-2400
-
-
Lund, O.1
Hansen, J.2
Soorensen, A.M.3
Mosekilde, E.4
Nielsen, J.O.5
Hansen, J.E.6
-
116
-
-
0031414824
-
Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): An accessory role for CR3 during virus entry?
-
DOI 10.1016/S0161-5890(97)00108-9, PII S0161589097001089
-
Stoiber H, Frank I, Spruth M, Schwendinger M, Mullauer B, Windisch JM et al. Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry? Mol Immunol 1997; 34: 855-863. (Pubitemid 28086167)
-
(1997)
Molecular Immunology
, vol.34
, Issue.12-13
, pp. 855-863
-
-
Stoiber, H.1
Frank, I.2
Spruth, M.3
Schwendinger, M.4
Mullauer, B.5
Windisch, J.M.6
Schneider, R.7
Katinger, H.8
Ando, I.9
Dierich, M.P.10
-
117
-
-
0035284808
-
desArg enhance the susceptibility of monocyte-derived macrophages to HIV infection
-
Kacani L, Banki Z, Zwirner J, Schennach H, Bajtay Z, Erdei A et al. C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection. J Immunol 2001; 166: 3410-3415. (Pubitemid 33117343)
-
(2001)
Journal of Immunology
, vol.166
, Issue.5
, pp. 3410-3415
-
-
Kacani, L.1
Banki, Z.2
Zwirner, J.3
Schennach, H.4
Bajtay, Z.5
Erdei, A.6
Stoiber, H.7
Dierich, M.P.8
-
118
-
-
34547856226
-
HIV-1 induced generation of C5a attracts immature dendritic cells and promotes infection of autologous T cells
-
DOI 10.1002/eji.200636820
-
Soederholm A, Banki Z, Wilflingseder D, Gassner C, Zwirner J, Lopez-Trascasa M et al. HIV-1 induced generation of C5a attracts immature dendriticcells and promotes infection of autologous T cells. Eur J Immunol 2007; 37: 2156-2163. (Pubitemid 47250208)
-
(2007)
European Journal of Immunology
, vol.37
, Issue.8
, pp. 2156-2163
-
-
Soederholm, A.1
Banki, Z.2
Wilflingseder, D.3
Gassner, C.4
Zwirner, J.5
Lopez-Trascasa, M.6
Falkensammer, B.7
Dierich, M.P.8
Stoiber, H.9
-
119
-
-
0036118228
-
Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons
-
DOI 10.1128/JVI.76.7.3179-3188.2002
-
Speth C, Schabetsberger T, Mohsenipour I, Stockl G, Wurzner R, Stoiber H et al. Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J Virol 2002; 76: 3179-3188. (Pubitemid 34224519)
-
(2002)
Journal of Virology
, vol.76
, Issue.7
, pp. 3179-3188
-
-
Speth, C.1
Schabetsberger, T.2
Mohsenipour, I.3
Stockl, G.4
Wurzner, R.5
Stoiber, H.6
Lass-Florl, C.7
Dierich, M.P.8
-
120
-
-
4644252300
-
Complement mediates the binding of HIV to erythrocytes
-
Horakova E, Gasser O, Sadallah S, Inal JM, Bourgeois G, Ziekau I et al. Complement mediates the binding of HIV to erythrocytes. J Immunol 2004; 173: 4236-4241. (Pubitemid 39280790)
-
(2004)
Journal of Immunology
, vol.173
, Issue.6
, pp. 4236-4241
-
-
Horakova, E.1
Gasser, O.2
Sadallah, S.3
Inal, J.M.4
Bourgeois, G.5
Ziekau, I.6
Klimkait, T.7
Schifferli, J.A.8
-
121
-
-
33747748773
-
Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells
-
Banki Z, Wilflingseder D, Ammann CG, Pruenster M, Mullauer B, Hollander K et al. Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells. J Immunol 2006; 177: 3469-3476. (Pubitemid 44277868)
-
(2006)
Journal of Immunology
, vol.177
, Issue.5
, pp. 3469-3476
-
-
Banki, Z.1
Wilflingseder, D.2
Ammann, C.G.3
Pruenster, M.4
Mullauer, B.5
Hollander, K.6
Meyer, M.7
Sprinzl, G.M.8
Van, L.J.9
Stellbrink, H.-J.10
Dierich, M.P.11
Stoiber, H.12
-
122
-
-
0037193837
-
Association of a pool of HIV-1 with erythrocytes in vivo: A cohort study
-
DOI 10.1016/S0140-6736(02)09291-7
-
Hess C, Klimkait T, Schlapbach L, del Zenero V, Sadallah S, Horakova E et al. Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study. Lancet 2002; 359: 2230-2234. (Pubitemid 34717976)
-
(2002)
Lancet
, vol.359
, Issue.9325
, pp. 2230-2234
-
-
Hess, C.1
Klimkait, T.2
Schlapbach, L.3
Del, Z.V.4
Sadallah, S.5
Horakova, E.6
Balestra, G.7
Werder, V.8
Schaefer, C.9
Battegay, M.10
Schifferli, J.-A.11
-
123
-
-
0034605036
-
B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells
-
Moir S, Malaspina A, Li Y, Chun TW, Lowe T, Adelsberger J et al. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J Exp Med 2000; 192: 637-646.
-
(2000)
J Exp Med
, vol.192
, pp. 637-646
-
-
Moir, S.1
Malaspina, A.2
Li, Y.3
Chun, T.W.4
Lowe, T.5
Adelsberger, J.6
-
124
-
-
0041474759
-
Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures
-
DOI 10.1002/eji.200323932
-
Dopper S, Wilflingseder D, Prodinger WM, Stiegler G, Speth C, Dierich MP et al. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures. Eur J Immunol 2003; 33: 2098-2107. (Pubitemid 37010026)
-
(2003)
European Journal of Immunology
, vol.33
, Issue.8
, pp. 2098-2107
-
-
Dopper, S.1
Wilflingseder, D.2
Prodinger, W.M.3
Stiegler, G.4
Speth, C.5
Dierich, M.P.6
Stoiber, H.7
-
125
-
-
0032904992
-
B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1
-
Jakubik JJ, Saifuddin M, Takefman DM, Spear GT. B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1. Immunology 1999; 96: 612-619.
-
(1999)
Immunology
, vol.96
, pp. 612-619
-
-
Jakubik, J.J.1
Saifuddin, M.2
Takefman, D.M.3
Spear, G.T.4
-
126
-
-
0033989551
-
Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes
-
Jakubik JJ, Saifuddin M, Takefman DM, Spear GT. Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes. J Virol 2000; 74: 552-555. (Pubitemid 30002940)
-
(2000)
Journal of Virology
, vol.74
, Issue.1
, pp. 552-555
-
-
Jakubik, J.J.1
Saifuddin, M.2
Takefman, D.M.3
Spear, G.T.4
-
127
-
-
70149114859
-
A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement
-
Xu Y, Zhang C, Jia L, Wen C, Liu H, Wang Y et al. A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement. Virol J 2009; 6: 123.
-
(2009)
Virol J
, vol.6
, pp. 123
-
-
Xu, Y.1
Zhang, C.2
Jia, L.3
Wen, C.4
Liu, H.5
Wang, Y.6
-
129
-
-
0030064149
-
Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55)
-
DOI 10.1084/jem.183.1.307
-
Stoiber H, Pinter C, Siccardi AG, Clivio A, Dierich MP. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J Exp Med 1996; 183: 307-310. (Pubitemid 26028772)
-
(1996)
Journal of Experimental Medicine
, vol.183
, Issue.1
, pp. 307-310
-
-
Stoiber, H.1
Pinter, C.2
Siccardi, A.G.3
Clivio, A.4
Dierich, M.P.5
-
130
-
-
16944363307
-
Neutralization of cytomegalovirus virions: The role of complement
-
Spiller OB, Hanna SM, Devine DV, Tufaro F. Neutralization of cytomegalovirus virions: the role of complement. J Infect Dis 1997; 176: 339-347. (Pubitemid 27328755)
-
(1997)
Journal of Infectious Diseases
, vol.176
, Issue.2
, pp. 339-347
-
-
Brad, S.O.1
Melanie, H.S.2
Devine, D.V.3
Tufaro, F.4
-
131
-
-
0034015604
-
Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts
-
DOI 10.1128/JVI.74.7.3264-3272.2000
-
Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000; 74: 3264-3272. (Pubitemid 30143751)
-
(2000)
Journal of Virology
, vol.74
, Issue.7
, pp. 3264-3272
-
-
Nguyen, D.H.1
Hildreth, J.E.K.2
-
132
-
-
0036301911
-
Herpes simplex virus 1 infected neuronal and skin cells differ in their susceptibility to complement attack
-
DOI 10.1046/j.1365-2567.2002.01421.x
-
Rautemaa R, Helander T, Meri S. Herpes simplex virus 1 infected neuronal and skin cells differ in their susceptibility to complement attack. Immunology 2002; 106: 404-411. (Pubitemid 34748135)
-
(2002)
Immunology
, vol.106
, Issue.3
, pp. 404-411
-
-
Rautemaa, R.1
Helander, T.2
Meri, S.3
-
133
-
-
0037399327
-
Viral mimicry of the complement system
-
Bernet J, Mullick J, Singh AK, Sahu A. Viral mimicry of the complement system. J Biosci 2003; 28: 249-264. (Pubitemid 36512801)
-
(2003)
Journal of Biosciences
, vol.28
, Issue.3
, pp. 249-264
-
-
Bernet, J.1
Mullick, J.2
Singh, A.K.3
Sahu, A.4
-
135
-
-
31844440174
-
Identification of a Naegleria fowleri membrane protein reactive with anti-human CD59 antibody
-
DOI 10.1128/IAI.74.2.1189-1195.2006
-
Fritzinger AE, Toney DM, MacLean RC, Marciano-Cabral F. Identification of a Naegleria fowleri membrane protein reactive with anti-human CD59 antibody. Infect Immun 2006; 74: 1189-1195. (Pubitemid 43185558)
-
(2006)
Infection and Immunity
, vol.74
, Issue.2
, pp. 1189-1195
-
-
Fritzinger, A.E.1
Toney, D.M.2
MacLean, R.C.3
Marciano-Cabral, F.4
-
136
-
-
0030813504
-
Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction
-
Saifuddin M, Hedayati T, Atkinson JP, Holguin MH, Parker CJ, Spear GT. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol 1997; 78: 1907-1911. (Pubitemid 27367673)
-
(1997)
Journal of General Virology
, vol.78
, Issue.8
, pp. 1907-1911
-
-
Saifuddin, M.1
Hedayati, T.2
Atkinson, J.P.3
Holguin, M.H.4
Parker, C.J.5
Spear, G.T.6
-
137
-
-
73949108246
-
A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: Implications for treatment of HIV-1/AIDS
-
Hu W, Yu Q, Hu N, Byrd D, Amet T, Shikuma C et al. A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS. J Immunol 2010; 184: 359-368.
-
(2010)
J Immunol
, vol.184
, pp. 359-368
-
-
Hu, W.1
Yu, Q.2
Hu, N.3
Byrd, D.4
Amet, T.5
Shikuma, C.6
-
138
-
-
0035760902
-
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: Further regulation by CD55 and CD59
-
Golay J, Lazzari M, Facchinetti V, Bernasconi S, Borleri G, Barbui T et al. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59. Blood 2001; 98: 3383-3389.
-
(2001)
Blood
, vol.98
, pp. 3383-3389
-
-
Golay, J.1
Lazzari, M.2
Facchinetti, V.3
Bernasconi, S.4
Borleri, G.5
Barbui, T.6
-
139
-
-
0034660092
-
Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis
-
Golay J, Zaffaroni L, Vaccari T, Lazzari M, Borleri GM, Bernasconi S et al. Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. Blood 2000; 95: 3900-3908. (Pubitemid 30412866)
-
(2000)
Blood
, vol.95
, Issue.12
, pp. 3900-3908
-
-
Golay, J.1
Zaffaroni, L.2
Vaccari, T.3
Lazzari, M.4
Borleri, G.-M.5
Bernasconi, S.6
Tedesco, F.7
Rambaldi, A.8
Introna, M.9
-
140
-
-
33644866786
-
Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines
-
Takei K, Yamazaki T, Sawada U, Ishizuka H, Aizawa S. Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines. Leuk Res 2006; 30: 625-631.
-
(2006)
Leuk Res
, vol.30
, pp. 625-631
-
-
Takei, K.1
Yamazaki, T.2
Sawada, U.3
Ishizuka, H.4
Aizawa, S.5
-
141
-
-
22544462219
-
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59
-
DOI 10.1002/eji.200425920
-
Ziller F, Macor P, Bulla R, Sblattero D, Marzari R, Tedesco F. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59. Eur J Immunol 2005; 35: 2175-2183. (Pubitemid 41015056)
-
(2005)
European Journal of Immunology
, vol.35
, Issue.7
, pp. 2175-2183
-
-
Ziller, F.1
Macor, P.2
Bulla, R.3
Sblattero, D.4
Marzari, R.5
Tedesco, F.6
-
142
-
-
79951970278
-
Neutralizing human antibodies against CD55 and CD59 targeted to lymphoma cells in vivo potentiate the therapeutic effect of Rituximab
-
Macor P, Piovan E, Zorzet S, Tripodo C, Marzari R, Amadori A et al.Neutralizing human antibodies against CD55 and CD59 targeted to lymphoma cells in vivo potentiate the therapeutic effect of Rituximab. Mol Immunol 2007; 44: 212.
-
(2007)
Mol Immunol
, vol.44
, pp. 212
-
-
Macor, P.1
Piovan, E.2
Zorzet, S.3
Tripodo, C.4
Marzari, R.5
Amadori, A.6
-
143
-
-
35948989248
-
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab
-
Macor P, Tripodo C, Zorzet S, Piovan E, Bossi F, Marzari R et al. In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. Cancer Res 2007; 67: 10556-10563.
-
(2007)
Cancer Res
, vol.67
, pp. 10556-10563
-
-
Macor, P.1
Tripodo, C.2
Zorzet, S.3
Piovan, E.4
Bossi, F.5
Marzari, R.6
-
144
-
-
0032562686
-
Identity of the residues responsible for the species-restricted complement inhibitory function of human CD59
-
DOI 10.1074/jbc.273.17.10665
-
Zhao XJ, Zhao J, Zhou Q, Sims PJ. Identity of the residues responsible for the species-restricted complement inhibitory function of human CD59. J Biol Chem 1998; 273: 10665-10671. (Pubitemid 28227680)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.17
, pp. 10665-10671
-
-
Zhao, X.-J.1
Zhao, J.2
Zhou, Q.3
Sims, P.J.4
-
145
-
-
0031041068
-
Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59
-
DOI 10.1084/jem.185.3.507
-
Bodian DL, Davis SJ, Morgan BP, Rushmere NK. Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59. J Exp Med 1997; 185: 507-516. (Pubitemid 27078369)
-
(1997)
Journal of Experimental Medicine
, vol.185
, Issue.3
, pp. 507-516
-
-
Bodian, D.L.1
Davis, S.J.2
Morgan, B.P.3
Rushmere, N.K.4
-
146
-
-
0029880993
-
Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59
-
DOI 10.1021/bi952862w
-
Husler T, Lockert DH, Sims PJ. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59. Biochemistry 1995; 35: 3263-3269. (Pubitemid 26082254)
-
(1996)
Biochemistry
, vol.35
, Issue.10
, pp. 3263-3269
-
-
Husler, T.1
Lockert, D.H.2
Sims, P.J.3
-
147
-
-
34249054072
-
Crystal structure of CD59: Implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex
-
DOI 10.1107/S0907444907015557, PII S0907444907015557
-
Huang Y, Fedarovich A, Tomlinson S, Davies C. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex. Acta Crystallogr D Biol Crystallogr 2007; 63: 714-721. (Pubitemid 46787696)
-
(2007)
Acta Crystallographica Section D: Biological Crystallography
, vol.63
, Issue.6
, pp. 714-721
-
-
Huang, Y.1
Fedarovich, A.2
Tomlinson, S.3
Davies, C.4
-
148
-
-
33748747546
-
Defining the CD59-C9 binding interaction
-
DOI 10.1074/jbc.M603690200
-
Huang Y, Qiao F, Abagyan R, Hazard S, Tomlinson S. Defining the CD59-C9 binding interaction. J Biol Chem 2006; 281: 27398-27404. (Pubitemid 44401767)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.37
, pp. 27398-27404
-
-
Huang, Y.1
Qiao, F.2
Abagyan, R.3
Hazard, S.4
Tomlinson, S.5
-
149
-
-
43549126221
-
Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection
-
Terpos E, Sarantopoulos A, Kouramba A, Katsarou O, Stavropoulos J, Masouridi S et al. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection. Med Sci Monit 2008; 14: CR276-CR280.
-
(2008)
Med Sci Monit
, vol.14
-
-
Terpos, E.1
Sarantopoulos, A.2
Kouramba, A.3
Katsarou, O.4
Stavropoulos, J.5
Masouridi, S.6
|